Advanced International Breast Cancer Course (AIBCC)

The 22nd edition of the Advanced International Breast Cancer Course (AIBCC) – Meet the Professor will be held on 17–18 September 2026 in Padua, Italy. The programme will feature an international faculty of leading experts who will present the latest advances in prevention, early diagnosis, and innovative therapeutic strategies, with a focus on improving both survival outcomes and quality of life for breast cancer patients.

Scientific Program

Thursday, September 17th

10.30	Introduction to the Conference
10.45	ESMO President Elect – Welcome Remark

SESSION I – HR+/HER2-

11.00	Clinical and biological definition of early and late risk of relapse
11.20	Navigating adjuvant ET options
11.40	Opportunities for radiation therapy de-escalation
12.00	Exploiting endocrine resistance in advanced disease
12.20	Revisited metastatic algorithm
12.40	Discussion
13.20	Lunch

SESSION II – HER2+

14.20	Turning biological heterogeneity into clinical action
14.40	Treatment escalation: neoadjuvant vs post-neoadjuvant strategies
15.00	Redefining 1st line for advanced disease: induction CT vs ADC? Duration? Which maintenance?
15.20	Discussion
15.40	Clinical Multidisciplinary Shooting Session 1 – HR+/HER2- and HER2+
17.00	Ceremony for the presentation of the University of Padua Award for Advances in Breast Cancer 2026 (Non-ECM)
17.15	Lecture of the Awardee (Non-ECM)
18.00	Adjourn

Friday, September 18th

SESSION III – TNBC

9.00	Markers of sensitivity/resistance to immunotherapy
9.20	Balancing escalation and de-escalation in eTNBC
9.40	1st line PD-L1+: ADC + ICI for all?
10.00	Discussion
10.20	Coffee break

SESSION IV – ROUND TABLE DISCUSSION: FOCUS ON YOUNG WOMEN

10.50	Fertility and pregnancy · Hereditary syndromes · Surgical management
12.00	Discussion
12.30	Lunch

SESSION V – HOT TOPICS

13.30	Clinical implications of liquid biopsy: MRD, monitoring, guide for target treatment
13.50	AI applied to histopathology
14.10	Dealing with new patterns of toxicity
14.30	The right to be forgotten: Ending Discrimination Against Cancer Survivors
14.50	Discussion
15.20	Clinical Multidisciplinary Shooting Session 2 – TNBC and special situations
16.40	Take home messages and adjourn

Faculty

Directors

Pierfranco Conte

Venezia (IT)

Scientific Director S. Camillo Hospital, IRCCS, Venezia (IT)

Valentina Guarneri

Padova (IT)

Division of Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Department of Surgery, Oncology and Gastroenterology, University of Padova (IT)

Philip Poortmans

Wilrijk-Antwerp (BE)

Former president of ESTRO and of ECCO, Department of Radiation Oncology, Iridium Netwerk, University of Antwerp (BE)

Aleix Prat

Barcelona (ES)

Clinic Barcelona Comprehensive Cancer Center, University of Barcelona – Barcelona (ES)

Scientific Committee

Bettina Borisch Institute of Global Health – Geneve (CH)

Maria Vittoria Dieci Division of Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Dept. of Surgery, Oncology and Gastroenterology – Padova (IT)

Hesham A. G. Elghazaly Dept. of Clinical Oncology and Nuclear Medicine, University of Ainshams – Cairo (EG)

Jacek Jassem Dept. of Oncology and Radiotherapy, Medical University of Gdansk (PL)

Stephen Johnston NIHR Biomedical Research Centre for Cancer, Royal Marsden NHS Foundation Trust & Institute of Cancer Research – London (UK)

Sibylle Loibl German Breast Group, University of Frankfurt (DE)

Eleftherios Mamounas Comprehensive Breast Program, MD Anderson Cancer Center Orlando – Orlando (US)

Fedro Alessandro Peccatori Dept. of Medical Oncology, European Institute of Oncology (IEO) – Milano (IT)

Sandra M. Swain Professor of Medicine, Associate Dean Research Development, Georgetown University Medical Center – Washington (US)

Advanced InternationalBreast Cancer Course